...
....
Pharmaceutical
Biotechnology

> See specialized channels
Medical Devices & Diagnostics
> See specialized channels
Industrial
Biotechnology
> See specialized channels


  Join us

  Follow us on Twitter   Join our LinkedIn Group   Our Blog

Biotech News App
Provides access to the latest biotech press releases ...more

Android_Logo App Store RIM_Logo_small

Media Partnership:
Want to have your RSS feed integrated on our website? Contact us
RSS Feeds RSS Feeds
JoomlaWatch Stats 1.2.9 by Matej Koval
For Editors
Sign up for press releases
For Companies
Sign up for our newsletter
Back to PRESS RELEASES - 

Vetter Wins the Axia Award

| Print |
Monday, 08 February 2010 17:30 (UTC + 1)

Vetter_logo

 

Leading pharma service provider recognized for its customer relationship management


Ravensburg, February 8, 2010 / b3c newswire / – Vetter, a leading provider of aseptic pre-filled injection systems, has been awarded the 2009 Axia Award for best customer relationship management. The prize was announced on February 4. Conferred yearly by the global auditing and consulting firm Deloitte, the award is given to medium-sized companies from Baden-Wuerttemberg, Germany, for sustainable and successful management. Udo J. Vetter, partner and chairman of Vetter´s advisory board, received the award on behalf of the company. Vetter, which works with 19 of the world’s top 20 pharmaceutical and biotechnology firms, establishes close working relationships with its clients through personal key account managers, who act as the customer’s central point of contact and as the interface with interdisciplinary project teams. The result is highly responsive service and effective performance. Such personalized care has contributed to the company’s growth. In the past five years, Vetter increased its sales by around € 100 million to over € 280 million. During the same period, the company headcount climbed from around 1,500 to 2,200.

 

“Vetter is a specialist in filling sensitive and high-end drug injection systems. Trust and reliability are therefore fundamental to successful collaborations with our clients,” says Vetter’s managing director Peter Soelkner. “Each of our clients is given individualized care through one key account manager, who becomes the customer’s permanent contact and link to experts throughout the company. Through regular visits, we get to know our customers better and understand their individual needs. That results in a true partnership, which enables excellent results for the client.”

 

For Christian Himmelsbach, partner in Deloitte’s Tax SME division, Vetter's professional customer relationship management was convincing. “Besides the usual approaches to customer relations, Vetter particularly impressed us with how extensively it collaborates with its clients in the development process of new products.”

 

Vetter recently founded a new subsidiary that combines global key account management and customer service. Key account managers cover key markets and are present at each client’s site. As a full-service provider, Vetter supports clients from clinical development through long-term market production. The company fills syringes, cartridges and vials for large and small clients across the international pharmaceutical and biotech industry.

 

Vetter_Axia_small

Picture Caption: Partner and chairman of Vetter´s advisory board, Udo J. Vetter (right), receives the 2009 Axia Award for customer relationship management, together with managing director Max Horn (middle) and division controller and manager of finance/IT, Titus Ottinger (left). (For a high resolution picture please right-click the image and select "Save Target As...")

 

 

About Vetter - www.vetter-pharma.com
Vetter is an independent international specialist in the aseptic filling of syringes, cartridges and vials. Based in Ravensburg, Germany, Vetter also produces its own injection systems, such as the Vetter Lyo-Ject® dual-chamber syringe. With about 2,200 employees worldwide, Vetter holds nearly 140 patents and has longstanding experience in handling client products and processes approved by the FDA, the EMA and other authorities. In 2007, the company also received approval as a foreign manufacturer for the Japanese pharmaceutical market from Japan’s Ministry for Health, Labor and Welfare. Additionally, Vetter has received two awards for its new facility Ravensburg Vetter South (RVS): The Facility of the Year Award 2007 (Process Innovation category) and the European Outsourcing Award 2007 (Most Improved Process/Plant/Facility category).
Vetter Development Service provides support for its pharmaceutical and biotech clients in the early stages of development, from clinical phases and regulatory approval to worldwide product launch. Vetter Commercial Manufacturing handles the entire production process, from compounding and aseptic filling to final product packaging. Vetter Solutions’ patented application systems enable clients to compete more effectively throughout the world.

 

 

For more information contact
Vetter Pharma International GmbH
Oskar Gold
Eywiesenstrasse 5
88212 Ravensburg
Germany
Phone: +49-(0)751-3700 - 0
Fax: +49-(0)751-3700 - 4000
E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
www.vetter-pharma.com